Two studies incorporating data from millions of patients highlight the need for consistent screening and access to supportive care.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Chang, W. H. & Lai, A. G. Nat. Med. https://doi.org/10.1038/s41591-022-01740-3 (2022).
Heinrich, M. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01745-y (2022).
Mitchell, A. J. et al. Lancet Oncol. 12, 160–174 (2011).
Riba, M. B. et al. J. Natl. Compr. Canc. Netw. 17, 1229–1249 (2019).
Bultz, B. D. & Carlson, L. E. J. Clin. Oncol. 23, 6440–6641 (2010).
US Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/core-patient-reported-outcomes-cancer-clinical-trials (2021).
Choueiri, T. K. & Motzer, R. J. N. Engl. J. Med. 376, 354–366 (2017).
Loo, V., Salgia, M., Bergerot, P., Philip, E. J. & Pal, S. K. Target. Oncol. 14, 639–645 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Bergerot, C.D., Pal, S.K. Shining a light on the psychological burden of cancer. Nat Med 28, 637–638 (2022). https://doi.org/10.1038/s41591-022-01763-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-01763-w
This article is cited by
-
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Nature Reviews Clinical Oncology (2023)